Live
- AP Legislative Council Approves Key Bills
- WhatsApp Update: WhatsApp Rolls Out Group Mentions in Status Updates
- Czech PM, European Council President-elect discuss cooperation, EU priorities
- 47 killed, 22 injured in Israeli airstrikes on Lebanon's Baalbek-Hermel
- Chandrababu Advocates for Balanced Governance and Development in Andhra Pradesh
- Our 6 free services in Delhi pinching rivals: Kejriwal at 'Revadi par Charcha' campaign
- Abu Dhabi T10: Jos Buttler shines in debut, lauds England batters after memorable performances
- BCCI releases dates for IPL 2025 to 2027
- Centre releases Rs 448 crore as grant for rural local bodies in Karnataka
- India and Japan bolster defence ties, explore air domain cooperation
Sun Pharma drops 7.5 per cent on Sebi report
Highlights
Shares of Sun Pharmaceutical Monday dived 75 per cent after reports that markets regulator Sebi may reopen an insider trading case against the firm and probe alleged lapses by some of its promoters The companys shares fell 752 per cent to end at Rs 45530 apiece on the BSE
​New Delhi: Shares of Sun Pharmaceutical Monday dived 7.5 per cent after reports that markets regulator Sebi may reopen an insider trading case against the firm and probe alleged lapses by some of its promoters. The company's shares fell 7.52 per cent to end at Rs 455.30 apiece on the BSE.
During the day, the stock declined 10.22 per cent to Rs 441.95. On the NSE, the scrip of the company slumped by 7.53 per cent to close at Rs 455.50. In terms of volume, over 48 lakh shares were traded on the BSE, while over 6 crore units changed hands on the NSE.
Next Story
ADVERTISEMENT
